Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
481 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT05326464 | Tofacitinib in Recurrent GBM Patients | completed | Phase 3 | 18 | University of Texas Southwestern Medical CenterOTHER | 1 | Jun 29, 2026 | clinicaltrials |
| NCT06712745 | Feasibility Study of Personalized Ultra-fractionated Stereotactic Ablative Radiotherapy (PULSAR) for Cancers of the Central Lung | recruiting | Early Phase 1 | 30 | University of Texas Southwestern Medical CenterOTHER | 1 | Jun 29, 2026 |
| NCT04172779 | Erlotinib for Hepatocellular Carcinoma Chemoprevention(ECHO-B) | not yet recruiting | Phase 2 | 60 | University of Texas Southwestern Medical CenterOTHER | 1 | Jun 24, 2026 | clinicaltrials |
| NCT07387666 | Imaging Acetadote Metabolism in Glioblastoma | recruiting | Early Phase 1 | 10 | University of Texas Southwestern Medical CenterOTHER | 1 | Jun 23, 2026 | clinicaltrials |
| NCT05537402 | LOcoregional vs Systemic Therapy in Patients With BCLC Stage B HCC(LOST-B) | terminated | Phase 2 | 1 | University of Texas Southwestern Medical CenterOTHER | 1 | Jun 18, 2026 | clinicaltrials |
| NCT04614194 | Single Cell Immune and Non-immune Correlates of Response to Neoadjuvant Abemaciclib | recruiting | Phase 2 | 60 | University of Texas Southwestern Medical CenterOTHER | 1 | Jun 17, 2026 | clinicaltrials |
| NCT05029999 | CD40 Agonist, Flt3 Ligand, and Chemotherapy in HER2 Negative Breast Cancer | recruiting | Phase 1 | 30 | University of Texas Southwestern Medical CenterOTHER | 1 | Jun 17, 2026 | clinicaltrials |
| NCT05999812 | Clinical Trial of All-trans-retinoic Acid, Bevacizumab and Atezolizumab in Colorectal Cancer | active not recruiting | Phase 2 | 22 | University of Texas Southwestern Medical CenterOTHER | 1 | Jun 17, 2026 | clinicaltrials |
| NCT03769766 | Trial of Curcumin to Prevent Progression of Low-risk Prostate Cancer Under Active Surveillance | recruiting | Phase 3 | 291 | University of Texas Southwestern Medical CenterOTHER | 1 | Jun 15, 2026 | clinicaltrials |
| NCT06825689 | Unidos Contra el VPH(Unidos) | recruiting | N/A | 735 | University of Texas at AustinOTHER | 1 | Jun 10, 2026 | clinicaltrials |
| NCT06085313 | Cancer Pain Management Using a Web-based Intervention(CAI) | recruiting | N/A | 300 | University of Texas at AustinOTHER | 1 | Jun 9, 2026 | clinicaltrials |
| NCT03525262 | Prostate Oncologic Therapy While Ensuring Neurovascular Conservation (POTEN-C)(POTEN-C) | active not recruiting | Phase 2 | 124 | University of Texas Southwestern Medical CenterOTHER | 1 | Jun 5, 2026 | clinicaltrials |
| NCT07183644 | Maximizing Laser Therapy Success for Port-Wine Birthmarks in Pediatric Patients | recruiting | N/A | 200 | University of Texas Southwestern Medical CenterOTHER | 1 | Jun 5, 2026 | clinicaltrials |
| NCT04796012 | VITAS: Atezolizumab in Combination With Chemotherapy for Pediatric Relapsed/Refractory Solid Tumors | recruiting | Phase 1 / Phase 2 | 23 | University of Texas Southwestern Medical CenterOTHER | 1 | Jun 2, 2026 | clinicaltrials |
| NCT06400550 | Identification of Metabolic Phenotypes Associated With Melanoma Metastasis | recruiting | — | 400 | University of Texas Southwestern Medical CenterOTHER | 1 | Jun 2, 2026 | clinicaltrials |
| NCT06727942 | Virtual Reality-Infused Treadmill Training on Aging-Related Outcomes(V-TARGET) | recruiting | N/A | 60 | The University of Texas at ArlingtonOTHER | 1 | May 29, 2026 | clinicaltrials |
| NCT05714826 | Comprehensive Optimization At-time of Radical Cystectomy Intervention(COARC) | withdrawn | N/A | 0 | University of Texas Southwestern Medical CenterOTHER | 0 | May 27, 2026 | clinicaltrials |
| NCT01668082 | An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection | recruiting | N/A | 40 | University of Texas Southwestern Medical CenterOTHER | 1 | May 19, 2026 | clinicaltrials |
| NCT07182045 | Impact of Uterine and Ovarian Vessel Occlusion on Blood Loss in High Burden Minimally Invasive Myomectomy.(Myo-Bleed) | recruiting | N/A | 120 | The University of Texas Health Science Center, HoustonOTHER | 1 | May 14, 2026 | clinicaltrials |
| NCT07136324 | Safety and Efficacy of EUS-RFA in the Treatment of Pancreatic Lesions: A Prospective Registry | active not recruiting | — | 100 | The University of Texas Health Science Center, HoustonOTHER | 1 | May 12, 2026 | clinicaltrials |
| NCT06800092 | Sildenafil to Prevent and Reduce Cancer Related Cognitive Impairment(SPARC) | not yet recruiting | Phase 2 / Phase 3 | 30 | The University of Texas Medical Branch, GalvestonOTHER | 1 | May 11, 2026 | clinicaltrials |
| NCT06768905 | IOMAB-CAR-T Followed by CAR-T Cell Therapy in R/R DLBCL | recruiting | Phase 1 / Phase 2 | 30 | University of Texas Southwestern Medical CenterOTHER | 1 | May 8, 2026 | clinicaltrials |
| NCT07574671 | Impact of Ketogenic Diet on Tumor Microenvironment in Patients With Breast Cancer | recruiting | N/A | 12 | The University of Texas Health Science Center at San AntonioOTHER | 1 | May 8, 2026 | clinicaltrials |
| NCT04130854 | INNATE: Immunotherapy During Neoadjuvant Therapy for Rectal Cancer | completed | Phase 2 | 58 | University of Texas Southwestern Medical CenterOTHER | 1 | May 6, 2026 | clinicaltrials |
| NCT04403620 | HYPORT: A Phase I/II Study of Hypofractionated Post-operative Radiation Therapy for Head and Neck Cancer | active not recruiting | Phase 1 / Phase 2 | 59 | University of Texas Southwestern Medical CenterOTHER | 1 | May 6, 2026 | clinicaltrials |
| NCT06266338 | Study of Pembrolizumab and Lenvatinib in Metastatic and Recurrent Cervix Cancer (LenPem Cervix) | recruiting | Phase 2 | 30 | University of Texas Southwestern Medical CenterOTHER | 1 | May 6, 2026 | clinicaltrials |
| NCT04786093 | Durvalumab and Stereotactic Radiotherapy for Advanced NSCLC | terminated | Phase 2 | 1 | University of Texas Southwestern Medical CenterOTHER | 1 | May 5, 2026 | clinicaltrials |
| NCT06598475 | Investigating Facilitator-driven, Multi-level Implementation Strategies in Federally Qualified Health Centers to Improve Provider Recommendation and HPV Vaccination Rates Among Latino/a Adolescents | recruiting | N/A | 225 | The University of Texas Health Science Center, HoustonOTHER | 1 | May 4, 2026 | clinicaltrials |
| NCT02095808 | Metabolic Biomarkers in Thoracic Cancers | recruiting | N/A | 200 | University of Texas Southwestern Medical CenterOTHER | 1 | May 1, 2026 | clinicaltrials |
| NCT05646485 | Bladder Cancer Screening Trial | recruiting | N/A | 1,000 | University of Texas Southwestern Medical CenterOTHER | 1 | May 1, 2026 | clinicaltrials |
| NCT03563976 | Multiparametric Image Analysis and Correlation With Outcomes in Lung Cancer Screening and Early Stage Lung Cancer | recruiting | — | 2,000 | University of Texas Southwestern Medical CenterOTHER | 1 | Apr 22, 2026 | clinicaltrials |
| NCT03568019 | PET Avidity in Cachexia-Inducing Lung and Gastrointestinal Tumors | active not recruiting | — | 10,000 | University of Texas Southwestern Medical CenterOTHER | 1 | Apr 21, 2026 | clinicaltrials |
| NCT03606317 | Retrospective Review of Cachexia in Lung and Gastrointestinal Cancer Patients | active not recruiting | — | 20,000 | University of Texas Southwestern Medical CenterOTHER | 0 | Apr 21, 2026 | clinicaltrials |
| NCT06163508 | A Long Term Follow-Up Study for Subjects Who Have Received Q-Cells | enrolling by invitation | — | 9 | University of Texas Southwestern Medical CenterOTHER | 1 | Apr 21, 2026 | clinicaltrials |
| NCT03655015 | Patient-derived Organoid Model and Circulating Tumor Cells for Treatment Response of Lung Cancer | recruiting | — | 150 | The University of Texas Health Science Center at San AntonioOTHER | 1 | Apr 20, 2026 | clinicaltrials |
| NCT03617237 | Registry Study to Evaluate the Clinical Outcome of Cancer Patients and Benign Diseases Treated With Radiation | recruiting | — | 10,000 | University of Texas Southwestern Medical CenterOTHER | 1 | Apr 17, 2026 | clinicaltrials |
| NCT05478694 | Outcomes of Focal Ablation for Prostate Cancer | recruiting | — | 225 | University of Texas Southwestern Medical CenterOTHER | 1 | Apr 17, 2026 | clinicaltrials |
| NCT06477692 | Invert-Prospective Phase II Randomized Trial of Involved Nodal Versus Elective Neck RadioTherapy | recruiting | Phase 2 | 80 | University of Texas Southwestern Medical CenterOTHER | 1 | Apr 17, 2026 | clinicaltrials |
| NCT02468024 | JoLT-Ca Sublobar Resection (SR) Versus Stereotactic Ablative Radiotherapy (SAbR) for Lung Cancer(STABLE-MATES) | recruiting | Phase 3 | 272 | University of Texas Southwestern Medical CenterOTHER | 4 | Apr 16, 2026 | clinicaltrials |
| NCT02645487 | Stereotactic Radiosurgery (SRS) Dose-Escalation Study for Brain Metastasis(SRS) | active not recruiting | N/A | 135 | University of Texas Southwestern Medical CenterOTHER | 1 | Apr 16, 2026 | clinicaltrials |
| NCT04600466 | Molecular and Epidemiological Risk Factors in the Development of Gastric Cancer | terminated | — | 129 | The University of Texas Health Science Center at San AntonioOTHER | 1 | Apr 14, 2026 | clinicaltrials |
| NCT05576974 | A Phase 2a, Single-dose, Open-label Study to Evaluate Diagnostic Performance and Safety of Pegsitacianine, an Intraoperative Fluorescence Imaging Agent for the Detection of Cancer, in Patients With Unknown Primary Head and Neck Cancer (ILLUMINATE STUDY) | recruiting | Phase 2 | 120 | University of Texas Southwestern Medical CenterOTHER | 1 | Apr 14, 2026 | clinicaltrials |
| NCT06044857 | PSMA PET Response Guided SabR in High Risk Pca | recruiting | Phase 1 | 20 | University of Texas Southwestern Medical CenterOTHER | 1 | Apr 14, 2026 | clinicaltrials |
| NCT04559230 | Sacituzumab Govitecan in Recurrent Glioblastoma | recruiting | Phase 2 | 32 | The University of Texas Health Science Center at San AntonioOTHER | 1 | Mar 30, 2026 | clinicaltrials |
| NCT07361874 | IMPACT-MACS: Adrenalectomy vs Semaglutide for Metabolic Outcomes in Mild Autonomous Cortisol Secretion(IMPACT-MACS) | recruiting | N/A | 75 | University of Texas Southwestern Medical CenterOTHER | 1 | Mar 27, 2026 | clinicaltrials |
| NCT04883281 | A Prospective Study of Daily Adaptive Radiotherapy to Better Organ-at-Risk Doses in Head and Neck Cancer(DARTBOARD) | completed | Phase 2 | 50 | University of Texas Southwestern Medical CenterOTHER | 1 | Mar 18, 2026 | clinicaltrials |
| NCT03747042 | Letrozole in Post-Menopausal Patients With Operable Hormone-Sensitive Breast Cancer | completed | Phase 2 | 61 | University of Texas Southwestern Medical CenterOTHER | 1 | Mar 16, 2026 | clinicaltrials |
| NCT03820687 | Improving Informed Decision Making for Cancer Clinical Trial Participation | active not recruiting | N/A | 581 | The University of Texas Health Science Center at San AntonioOTHER | 1 | Mar 13, 2026 | clinicaltrials |
| NCT05479123 | Assessing the Impact of Dosage Frequency of Propranolol on Sleep Patterns in Patients With Infantile Hemangiomas | terminated | Phase 4 | 52 | The University of Texas Health Science Center, HoustonOTHER | 1 | Mar 13, 2026 | clinicaltrials |
| NCT03067467 | Metabolic Characteristics of Brain Tumors Using Hyperpolarized Carbon-13 Magnetic Resonance Spectroscopic Imaging (MRSI)(HPCIM) | recruiting | — | 25 | University of Texas Southwestern Medical CenterOTHER | 1 | Mar 10, 2026 | clinicaltrials |
Data updated 23 days agoSource updated unknownsource: clinicaltrials